| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1174.59 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1174.59. The average price that MTD shares were previous bought at was USD 1243.67. The current market price is -5.6% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 934,041 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 84.44 | USD 0 | The current share valuation price of COO based on adjusted close was USD 84.44. The average price that COO shares were previous bought at was USD 89.3623. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in COO has increased by USD 208,183 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 233.1 | USD 0 | The current share valuation price of STE based on adjusted close was USD 233.1. The average price that STE shares were previous bought at was USD 221.869. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in STE has increased by USD 313,096 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 98.22 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 98.22. The average price that ZBH shares were previous bought at was USD 107.315. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 281,892 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 366.67 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 366.67. The average price that WAT shares were previous bought at was USD 371.034. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in WAT has increased by USD 631,881 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 366.67 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 366.67. The average price that WAT shares were previous bought at was USD 371.034. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in WAT has increased by USD 631,881 compared to the previous valuation of Waters Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 219.46 | USD 0 | The current share valuation price of WST based on adjusted close was USD 219.46. The average price that WST shares were previous bought at was USD 260.627. The current market price is -15.8% lower than average price they were purchased at. The value of the holding in WST has increased by USD 219,744 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 124.4 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 124.4. The average price that BIIB shares were previous bought at was USD 145.76. The current market price is -14.7% lower than average price they were purchased at. The value of the holding in BIIB has increased by USD 430,194 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1174.59 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1174.59. The average price that MTD shares were previous bought at was USD 1243.67. The current market price is -5.6% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 934,041 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 250.94 | USD 0 | The current share valuation price of LH based on adjusted close was USD 250.94. The average price that LH shares were previous bought at was USD 241.241. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in LH has increased by USD 204,471 compared to the previous valuation of Laboratory Corporation of America Holdings however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 85.05 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 85.05. The average price that DXCM shares were previous bought at was USD 78.1694. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in DXCM has increased by USD 70,873 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 148.62 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 148.62. The average price that CAH shares were previous bought at was USD 128.156. The current market price is 16.0% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 46,141 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 62.87 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 62.87. The average price that CNC shares were previous bought at was USD 60.2747. The current market price is 4.3% higher than average price they were purchased at. The value of the holding in CNC has increased by USD 19,004 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 252.86 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 252.86. The average price that HUM shares were previous bought at was USD 271.108. The current market price is -6.7% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 189,520 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 252.86 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 252.86. The average price that HUM shares were previous bought at was USD 271.108. The current market price is -6.7% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 189,520 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 509.53 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 509.53. The average price that IDXX shares were previous bought at was USD 439.64. The current market price is 15.9% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 689,005 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 755.57 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 755.57. The average price that LLY shares were previous bought at was USD 835.154. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in LLY has increased by USD 7,857,906 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 98.5 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 98.5. The average price that RVTY shares were previous bought at was USD 112.487. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in RVTY has increased by USD 423,524 compared to the previous valuation of Revvity Inc. however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 144.43 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 144.43. The average price that DVA shares were previous bought at was USD 155.057. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in DVA has increased by USD 14,500 compared to the previous valuation of DaVita HealthCare Partners Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 70.47 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 70.47. The average price that HSIC shares were previous bought at was USD 72.9404. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in HSIC has increased by USD 109,312 compared to the previous valuation of Henry Schein Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 74.8 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 74.8. The average price that SOLV shares were previous bought at was USD 74.1331. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in SOLV has increased by USD 293,541 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| CRL - Creightons Plc | HOLD | 0 @ USD 143.08 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 143.08. The average price that CRL shares were previous bought at was USD 168.42. The current market price is -15.0% lower than average price they were purchased at. The value of the holding in CRL has increased by USD 106,735 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 53.9 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 53.9. The average price that TECH shares were previous bought at was USD 65.7372. The current market price is -18.0% lower than average price they were purchased at. The value of the holding in TECH has increased by USD 296,822 compared to the previous valuation of Bio-Techne Corp however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 191.55 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 191.55. The average price that UHS shares were previous bought at was USD 188.952. The current market price is 1.4% higher than average price they were purchased at. The value of the holding in UHS has increased by USD 268,265 compared to the previous valuation of Universal Health Services Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 60.85 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 60.85. The average price that INCY shares were previous bought at was USD 69.1868. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in INCY has increased by USD 144,069 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 25.7 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 25.7. The average price that MRNA shares were previous bought at was USD 35.6316. The current market price is -27.9% lower than average price they were purchased at. The value of the holding in MRNA has increased by USD 230,040 compared to the previous valuation of Moderna Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 247.66 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 247.66. The average price that RMD shares were previous bought at was USD 234.608. The current market price is 5.6% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 182,991 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 8.96 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 8.96. The average price that VTRS shares were previous bought at was USD 10.4367. The current market price is -14.1% lower than average price they were purchased at. The value of the holding in VTRS has increased by USD 109,074 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 189 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 189. The average price that ALGN shares were previous bought at was USD 189.684. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in ALGN has increased by USD 240,848 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 31.88 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 31.88. The average price that BAX shares were previous bought at was USD 33.2799. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 236,339 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 175.9 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 175.9. The average price that DGX shares were previous bought at was USD 166.372. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in DGX has fallen by USD 56,330 compared to the previous valuation of Quest Diagnostics Incorporated |
| HOLX - Hologic Inc | HOLD | 0 @ USD 58.81 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 58.81. The average price that HOLX shares were previous bought at was USD 67.1534. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in HOLX has increased by USD 219,575 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 327.69 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 327.69. The average price that MOH shares were previous bought at was USD 309.151. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in MOH has increased by USD 144,046 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MOH - MOH | HOLD | 0 @ USD 327.69 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 327.69. The average price that MOH shares were previous bought at was USD 309.151. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in MOH has increased by USD 144,046 compared to the previous valuation of MOH however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 561.43 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 561.43. The average price that ISRG shares were previous bought at was USD 543.683. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 4,220,850 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 439.37 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 439.37. The average price that VRTX shares were previous bought at was USD 476.99. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in VRTX has increased by USD 1,751,886 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 388.08 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 388.08. The average price that SYK shares were previous bought at was USD 380.087. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in SYK has increased by USD 1,167,754 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 102.87 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.87. The average price that BSX shares were previous bought at was USD 98.7077. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 6,999 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 102.87 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.87. The average price that BSX shares were previous bought at was USD 98.7077. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 6,999 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 23.09 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 23.09. The average price that PFE shares were previous bought at was USD 25.8453. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in PFE has increased by USD 2,179,917 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 200.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 200.83. The average price that DHR shares were previous bought at was USD 218.066. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in DHR has increased by USD 3,375,655 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 200.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 200.83. The average price that DHR shares were previous bought at was USD 218.066. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in DHR has increased by USD 3,375,655 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 274.76 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 274.76. The average price that AMGN shares were previous bought at was USD 302.331. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in AMGN has increased by USD 2,270,594 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 74.11 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 74.11. The average price that GEHC shares were previous bought at was USD 85.0505. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in GEHC has increased by USD 916,463 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 131.99 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 131.99. The average price that ABT shares were previous bought at was USD 126.633. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in ABT has fallen by USD 1,029,614 compared to the previous valuation of Abbott Laboratories |
| TMO - Time Out Group plc | HOLD | 0 @ USD 432.59 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 432.59. The average price that TMO shares were previous bought at was USD 524.88. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in TMO has increased by USD 5,351,497 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 80.43 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 80.43. The average price that MRK shares were previous bought at was USD 92.1851. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 5,357,932 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 80.43 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 80.43. The average price that MRK shares were previous bought at was USD 92.1851. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 5,357,932 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 190.07 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 190.07. The average price that ABBV shares were previous bought at was USD 192.604. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in ABBV has increased by USD 4,585,895 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 154.14 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 154.14. The average price that JNJ shares were previous bought at was USD 157.556. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in JNJ has fallen by USD 91,471 compared to the previous valuation of Johnson & Johnson |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 378.75 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 378.75. The average price that UNH shares were previous bought at was USD 526.151. The current market price is -28.0% lower than average price they were purchased at. The value of the holding in UNH has fallen by USD 826,012 compared to the previous valuation of UnitedHealth Group Incorporated |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 161.92 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 161.92. The average price that ZTS shares were previous bought at was USD 167.269. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 563,549 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 156.13 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 156.13. The average price that IQV shares were previous bought at was USD 192.722. The current market price is -19.0% lower than average price they were purchased at. The value of the holding in IQV has increased by USD 567,366 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 115.55 | USD 0 | The current share valuation price of A based on adjusted close was USD 115.55. The average price that A shares were previous bought at was USD 130.062. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in A has increased by USD 1,165,320 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 74.8 | USD 0 | The current share valuation price of EW based on adjusted close was USD 74.8. The average price that EW shares were previous bought at was USD 71.1512. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in EW has increased by USD 313,974 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 278.38 | USD 0 | The current share valuation price of COR based on adjusted close was USD 278.38. The average price that COR shares were previous bought at was USD 254.014. The current market price is 9.6% higher than average price they were purchased at. The value of the holding in COR has fallen by USD 378,429 compared to the previous valuation of Cencora Inc. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 363.28 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 363.28. The average price that HCA shares were previous bought at was USD 336.814. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in HCA has increased by USD 813,562 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 175.34 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 175.34. The average price that BDX shares were previous bought at was USD 227.605. The current market price is -23.0% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 1,110,329 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 64.81 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 64.81. The average price that CVS shares were previous bought at was USD 62.5524. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 1,293,302 compared to the previous valuation of CVS Health Corp |
| MCK - McKesson Corporation | HOLD | 0 @ USD 687.52 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 687.52. The average price that MCK shares were previous bought at was USD 619.119. The current market price is 11.0% higher than average price they were purchased at. The value of the holding in MCK has fallen by USD 353,549 compared to the previous valuation of McKesson Corporation |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 575.63 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 575.63. The average price that REGN shares were previous bought at was USD 704.833. The current market price is -18.3% lower than average price they were purchased at. The value of the holding in REGN has increased by USD 2,397,285 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 315.74 | USD 0 | The current share valuation price of CI based on adjusted close was USD 315.74. The average price that CI shares were previous bought at was USD 315.656. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in CI has fallen by USD 2,304,291 compared to the previous valuation of Cigna Corp |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 416.69 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 416.69. The average price that ELV shares were previous bought at was USD 410.268. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in ELV has increased by USD 1,328,661 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 416.69 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 416.69. The average price that ELV shares were previous bought at was USD 410.268. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in ELV has increased by USD 1,328,661 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 85.81 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 85.81. The average price that MDT shares were previous bought at was USD 88.747. The current market price is -3.3% lower than average price they were purchased at. The value of the holding in MDT has increased by USD 1,418,863 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 103.82 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 103.82. The average price that GILD shares were previous bought at was USD 102.598. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 4,089,649 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 48.18 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 48.18. The average price that BMY shares were previous bought at was USD 57.416. The current market price is -16.1% lower than average price they were purchased at. The value of the holding in BMY has increased by USD 1,667,246 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-05-12 this would crystalise an overall loss. |
| PODD - Insulet Corporation | SELL | -38 @ USD 316.67 | USD -12,033 | The ETF sold 38 shares of PODD on 2025-05-12. The shares were previously bought for an average price of USD 268.147. The Insulet Corporation shares were sold for 18.1% higher than average price of previous purchases. This sale made a profit of USD 1,844 The average price that the ETF previously sold PODD share for is USD 261.843 so the ETF has sold 38 shares on 2025-05-12 at a higher price than the previous selling average. |